Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CGTX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in COGNITION THERAPEUTICS INC
Yes. Vanguard Capital Management holds 3,438,775 shares of CGTX (Cognition Therapeutics), worth $4M, as of its Q2 2026 13F filing. It increased the position by 436,988 shares (+14.6%) from Q1 2026. Vanguard Capital Management has held CGTX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$4M
Current Shares
3.4M
Total Value Change
+$1.7M
Total Shares Change
+436,988
Quarter-by-Quarter History
Other major holders of CGTX: DAVENPORT & Co LLC, VANGUARD GROUP INC, Pathstone Holdings, LLC